First FDA EUA for Breath-Based COVID Test in Hand, InspectIR Focusing on Commercialization
The company's breath test uses mass spectrometry to determine a user's response to the presence of SARS-CoV-2.
Source: 360dx.com
Stay updated with breaking news from Deep Sensing Algorithms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company's breath test uses mass spectrometry to determine a user's response to the presence of SARS-CoV-2.
Finnish healthtech innovations and solutions are part of the diagnostic technology and applications that are reshaping healthcare as we emerge into a post-pandemic world.
The firm's DSA BreathPass device measures a pattern of metabolic signatures found in a user's breath to determine the presence of SARS-CoV-2.
The handheld device sends data via a mobile app to a cloud-based service, which provides a test result within a few seconds.